Matribhumi Samachar English
San Diego, California–(Newsfile Corp. – August 1, 2025) – Thiogenesis Therapeutics Corp. (TSXV: TTI) (“Thiogenesis” or the “Company”) is pleased to announce that, further to its news releases of July 17 and July 29, 2025, it has closed a heavily over-subscribed non-brokered private placement (the “Offering”) through the issuance of …
Read More »Thiogenesis Announces Non-Brokered Private Placement of Common Shares
San Diego, California–(Newsfile Corp. – July 17, 2025) – Thiogenesis Therapeutics Corp. (TSXV: TTI) (“Thiogenesis” or the “Company”) announced today that it will undertake a non-brokered private placement (the “Offering”) of 2,000,000 common shares of the Company (“Offered Shares”) at a price of $0.75 per Common Share for gross proceeds …
Read More »